ARCHIVES

FDA Approves Tamoxifen For “Reduction In Incidence,” Avoids Word “Prevention”

This article is from The Cancer Letter archive.

Vol. 24 No. 42 | November 6, 1998

Download PDF Visit The Full Archive

Related Articles

ODAC Supports Approval For Taxotere In Breast Cancer, Hycamtin In Lung Cancer

June 5, 1998

Canadian NCI Plans Review Of National Breast Screening Study

February 24, 1995

UNM Gets $1.8 Million For Nanotechnology Center

February 18, 2011

Study Tests PARP Inhibitor ABT-888 For Several Cancers

September 25, 2009

NCAB to Get NCI Bypass Budget May 13; DeVita Tells Centers That Is Where “Our Philosophy Can Be Found”

May 3, 1985

NEJM Paper Ignites Debate Over Spiral CT Scans For Lung Cancer.

November 3, 2006